Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01134900 · ClinicalTrials.gov registry record · NA

Achieving Medication Safety During Acute Kidney Injury

A NA study, sponsored by Vanderbilt University.

Completed
Registry status
NA
Development phase
540
Enrollment target

NCT01134900 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 540 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01134900, a NA study, has completed, sponsored by Vanderbilt University.

COMPLETED
Registry status
NA
Development phase
540 participants
Enrollment target

Study Summary

The utilization of clinical decision support (CDS) is increasing among healthcare facilities which have implemented computerized physician order entry or electronic medical records. Formal prospective evaluation of CDS implementations occurs rarely, and misuse or flaws in system design are often unrecognized. Retrospective review can identify failures but is too late to make critical corrections or initiate redesign efforts. A real-time surveillance dashboard for high-alert medications integrates externalized CDS interactions with relevant medication ordering, administration, and therapeutic monitoring data. The surveillance view of the dashboard displays all currently admitted, eligible patients and provides brief demographics with triggering order, laboratory, and CDS failure data to allow prioritization of high-risk scenarios. The patient detail view displays a detailed timeline of orders, order administrations, laboratory values, and CDS interactions for an individual patient and allows users to understand provider actions and patient condition changes occurring in conjunction with CDS failures. Clinical pharmacists' use of the dashboard for patient monitoring and intervention aims to increase the rate and timeliness of intercepted medication errors compared to CPOE-based CDS in the setting of acute kidney injury, which affects patients at various points across all hospital units and services and has numerous opportunities for intervention.

Interventions

  • OTHER Pharmacy Dashboard Review and Intervention

Trial Details

FieldValue
Enrollment Target 540 participants
Start Date 2010-06
Est. Completion 2010-08
Phase NA

Sponsor

Vanderbilt University

430 total trials

What the Registry Record Tells You About NCT01134900

The ClinicalTrials.gov registry entry for NCT01134900 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 540 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Pharmacy Dashboard Review and Intervention is the first listed.

NCT01134900 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01134900 about?

NCT01134900 is a clinical study titled "Achieving Medication Safety During Acute Kidney Injury". The utilization of clinical decision support (CDS) is increasing among healthcare facilities which have implemented computerized physician order entry or electronic medical records. Formal prospective evaluation of CDS implementations occurs rarely, and misuse or flaws in system design are often unr...

What is the current status of trial NCT01134900?

This trial is currently completed. It is a NA study. The enrollment target is 540 participants. The study started on 2010-06. Estimated completion is 2010-08.

What interventions are being tested in trial NCT01134900?

The interventions under investigation include: Pharmacy Dashboard Review and Intervention (OTHER).

Who is sponsoring clinical trial NCT01134900?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.